Evidence map›Paper›PMID 18500245›Full record

ReviewNature reviews. Cancer2008

Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer.

David Frescas, Michele Pagano

Abstract readReview
In one paragraph

Review in Nature reviews. Cancer, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 583 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
583citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

583 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Bioinformatics analysis and clinical validation identifyTranslational andrology and urology · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. E3 ubiquitin ligase SKP2 limits autophagosome formation duringFrontiers in cellular and infection microbiology · 2026
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

523 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

David FrescasDepartment of Pathology, NYU Cancer Institute, New York University School of Medicine, 550 First Avenue, New York, New York 10016, USA.
Michele Pagano

Funding

REGULATION OF THE GI PHASE BY THE UBIQUITIN PATHWAYR01GM057587 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PAGANO, MICHELE · 1998 to 2018
$7.8M
F-box proteins: deregulated cell cycle control and proteolysis in cancerR37CA076584 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PAGANO, MICHELE · 2006 to 2016
$4.7M
Novel Substrates of SCF Ubiquitin Ligases in Cell Cycle Control and CancerR21CA125173 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PAGANO, MICHELE · 2007 to 2008
$372k
Howard Hughes Medical InstituteNCI NIH HHS P30-CA01687NCI NIH HHS R21-CA125173NCI NIH HHS R37-CA76584NIGMS NIH HHS R01 GM057587NIGMS NIH HHS R01-GM57587
6 · The paper itself

Abstract

The maintenance and preservation of distinct phases during the cell cycle is a highly complex and coordinated process. It is regulated by phosphorylation--through the activity of cyclin-dependent kinases (CDKs)--and protein degradation, which occurs through ubiquitin ligases such as SCF (SKP1-CUL1-F-box protein) complexes and APC/C (anaphase-promoting complex/cyclosome). Here, we explore the functionality and biology of the F-box proteins, SKP2 (S-phase kinase-associated protein 2) and beta-TrCP (beta-transducin repeat-containing protein), which are emerging as important players in cancer biogenesis owing to the deregulated proteolysis of their substrates.

Indexed as

AnimalsApoptosis Regulatory Proteinsbeta-Transducin Repeat-Containing Proteinscdc25 PhosphatasesCell Cycle ProteinsCo-Repressor ProteinsCullin ProteinsCyclin-Dependent Kinase Inhibitor p27Cyclin-Dependent KinasesDNA-Binding ProteinsForkhead Box Protein O1Forkhead Transcription FactorsHumansNeoplasm ProteinsNeoplasmsNerve Tissue ProteinsApoptosis Regulatory Proteinsbeta-Transducin Repeat-Containing ProteinsCDC25A protein, humancdc25 PhosphatasesCell Cycle ProteinsCo-Repressor ProteinsCullin 1Cullin ProteinsCyclin-Dependent Kinase Inhibitor p27Cyclin-Dependent KinasesDNA-Binding ProteinsForkhead Box Protein O1Forkhead Transcription FactorsFOXO1 protein, humanNeoplasm ProteinsNerve Tissue ProteinsNF-kappa BPDCD4 protein, humanRCOR1 protein, humanRepressor ProteinsRNA-Binding ProteinsSKP Cullin F-Box Protein LigasesS-Phase Kinase-Associated Proteins

Identifiers

PMID18500245
PMCPMC2711846

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.